SNY — Sanofi
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1121404 ·
Last close
$42.95
Market Cap
$102.81B
52W High
$46.05
52W Low
$40.89
ADV30
3,449,263
Next earnings
2026-07-30
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 11,244,000,000 | 8,106,000,000 | 2,269,000,000 | 1,614,000,000 | 128,024,000,000 | 5,544,000,000 | 54,881,000,000 |
| Dec 2025 | 12,205,000,000 | 8,449,000,000 | 1,630,000,000 | -801,000,000 | 126,805,000,000 | 7,657,000,000 | 55,095,000,000 |
| Sep 2025 | 13,170,000,000 | 9,758,000,000 | 3,785,000,000 | 2,802,000,000 | 129,794,000,000 | 8,906,000,000 | 56,261,000,000 |
| Jun 2025 | 10,735,000,000 | 7,743,000,000 | 1,712,000,000 | 3,940,000,000 | 124,959,000,000 | 15,359,000,000 | 54,680,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$10,336,000,000
Investing CF
$-14,175,000,000
Financing CF
$-9,102,000,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$2.25
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
—
Inventory
$23,503,000,000
Receivables
$482,000,000
ST Investments
—
EBIT TTM
$6,550,000,000
Pretax Income TTM
$6,020,000,000
Interest Exp TTM
$530,000,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$47,353,999,360
EBITDA
$12,826,999,808
Free Cash Flow
$16,672,499,712
Enterprise Value
$118,252,781,568
Total Cash
$5,544,000,000
Total Debt
$20,021,000,192
Shares Out
2,393,769,026
Trailing EPS
$2.25
Book Value
$34.40
ROE
6.6%
ROA
4.7%
Div Yield
5.63%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 46,716,000,000 | 9,597,000,000 | 7,813,000,000 | 126,805,000,000 | 55,095,000,000 | — | 10,750,000,000 |
| Dec 2024 | 44,286,000,000 | 8,923,000,000 | 5,560,000,000 | 132,798,000,000 | 54,941,000,000 | — | 9,081,000,000 |
| Dec 2023 | 41,618,000,000 | 8,691,000,000 | 5,400,000,000 | 126,464,000,000 | 52,111,000,000 | — | 10,258,000,000 |
| Dec 2022 | 40,561,000,000 | 10,926,000,000 | 8,371,000,000 | 126,722,000,000 | 51,570,000,000 | — | 10,526,000,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$5.29
Max Pain — expiry 2026-07-17
max pain strike: $42.50 · spot: $43.10 · call oi: 6,526 · put oi: 3,062
Expected Move to 2026-07-17:
±$1.90
(4.41%) —
implied range
$41.20 –
$45.00
· ATM straddle on $42.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SNYNF | Sanofi | $101.95B | $85.18 | — |
| GLAXF | GSK plc | $101.49B | $25.33 | — |
| GSK | GSK plc | $105.17B | $52.50 | — |
| BMY | BRISTOL MYERS SQUIBB CO | $117.46B | $57.52 | — |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | $124.70B | $491.34 | — |
News headlines (Yahoo Finance, 1h cache)
Deutsche Bank Cuts PT on Sanofi (SNY) – Here’s Why
2026-06-27 19:10 · Yahoo
BofA Expects Positive Investor Reaction to Leadership Update at Sanofi (SNY)
2026-06-27 04:14 · Yahoo
Sanofi Faces EU Probe With Fines Possibly Reaching 10%
2026-06-26 17:38 · Yahoo
Sanofi Faces EU Antitrust Probe Over Flu Vaccine Communication Campaign
2026-06-26 10:51 · Yahoo
EU hits France's Sanofi with flu vaccine antitrust probe
2026-06-26 10:46 · Yahoo
Is Kymera Therapeutics The Next Big Rival To Regeneron And Sanofi?
2026-06-25 20:57 · Yahoo
Is AbbVie a Buy After Its Purchase of Apogee?
2026-06-25 14:13 · Yahoo
REPLAY: Fireside Chat with NanoViricides President & Exec. Chairman Anil R. Diwan
2026-06-25 13:00 · Yahoo
Press Release: Sanofi Foundation opens new chapter centered on future generations
2026-06-25 06:00 · Yahoo
Chronic Spontaneous Urticaria Market Heats Up as Pharma Companies Race to Address Unmet Needs | DelveInsight
2026-06-24 14:31 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.